Mesenchymal Stem Cells（UMC Utrecht）

N/A

Report date: 2023/08/02 20:00:51

Base Information

Drug NameMesenchymal Stem Cells（UMC Utrecht）

Drug Alias NameBone Marrow-derived Allogeneic Mesenchymal Cells（UMC Utrecht）

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsIschemic StrokeStroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesUmc Utrecht

China Registration ClassN/A

Develop Information

Active CompaniesUmc Utrecht

Inactive CompaniesN/A

Active IndicationsIschemic StrokeStroke

Inactive IndicationsN/A

Other Information

ATC CodeN/A